As always, it is important to discuss the potential risks and benefits of semaglutide use with your healthcare provider before starting treatment
How much your body needs depends on several things, including body type, activity level, and environment
Despite the rapid uptake of these therapies, the broader trends in who uses these drugs and the associated payments across GLP-1RA subtypes and diabetes status have not been well characterized using nationally representative US data
This massive multicenter study included 810,390 new semaglutide users and found NAION incidence rates of 14.5 per 100,000 person-years among semaglutide patients, with increased risks particularly evident at the 2-year, 3-year, and 4-year timepoints following treatment initiation
If youre experiencing side effects, talk to your Achieve medical team